| Literature DB >> 26889757 |
Owen S Fenton1,2, Kevin J Kauffman1,3, Rebecca L McClellan1, Eric A Appel1, J Robert Dorkin1,4, Mark W Tibbitt1, Michael W Heartlein5, Frank DeRosa5, Robert Langer1,3,6,7, Daniel G Anderson1,3,6,7.
Abstract
Thousands of human diseases could be treated by selectively controlling the expression of specific proteins in vivo. A new series of alkenyl amino alcohol (AAA) ionizable lipid nanoparticles (LNPs) capable of delivering human mRNA with unprecedented levels of in vivo efficacy is demonstrated. This study highlights the importance of utilizing synthesis tools in tandem with biological inspiration to understand and improve nucleic acid delivery in vivo.Entities:
Keywords: RNA; biomaterials; drug delivery; nanoparticles; proteins
Mesh:
Substances:
Year: 2016 PMID: 26889757 PMCID: PMC5245883 DOI: 10.1002/adma.201505822
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849